Proteases, Protease Inhibitors and Protease-Derived Peptides : Importance in Human Pathophysiology and Therapeutics (Agents and Actions Supplements .42) / Cheronis, J./ Repine

Proteases, Protease Inhibitors and Protease-Derived Peptides : Importance in Human Pathophysiology and Therapeutics (Agents and Actions Supplements .42) （Softcover reprint of the original 1st ed. 1993. 2012. viii, 248 S. VII）

個数：

Proteases, Protease Inhibitors and Protease-Derived Peptides : Importance in Human Pathophysiology and Therapeutics (Agents and Actions Supplements .42) （Softcover reprint of the original 1st ed. 1993. 2012. viii, 248 S. VII）

Cheronis, J./ Repine

ドイツ（DK）から取り寄せる

ウェブストア価格 ¥12,620（本体¥11,473）
SPRINGER, BASEL; BIRKHÄUSER BASEL; BIRKHÄUSER（2012発売）
外貨定価 EUR 53.49
ポイント 114pt

在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合がございます。
2. 複数冊ご注文の場合、分割発送となる場合がございます。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

アメリカ（US）から取り寄せる

ウェブストア価格 ¥11,148（本体¥10,135）
SPRINGER, BASEL; BIRKHÄUSER BASEL; BIRKHÄUSER（2012発売）
外貨定価 US$ 54.99
ポイント 101pt

オンデマンド(OD/POD)版です。キャンセルは承れません。

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 260 p.
言語 ENG
商品コード 9783034873994

Full Description

Proteases, Protease-Derived Peptides and Protease Inhibitors Many physiological as weil as pathophysiological processes are mediated by proteases and the products of their actions, protease-derived peptides. However, the uncontrolled activity of proteases can be extraordinarily destructive and dangerous to normal biologie systems. As a result, biology has gone to great lengths to control the activities of the proteases involved in these systems by developing aseries of both highly specific (regulatory) and non-specific (protective) anti-proteases. The protease/anti-protease balancing activities include the normal homeostatic processes of clotting and clot lysis, hormonal regulation of blood pressure and the control of the inflammatory response represented by both the humoral (the kallikrein-kinin and complement systems) and cellular (neutrophil and macrophage derived proteases) components of the inflammation. Examples of successful therapies directed at these protease dependent systems include the use of warfarin and heparin to control thrombosis and streptokinase or tissue plasminogen activator (tPA) for the acceleration of clot dissolution.
Similarly, the use of angiotensin converting enzyme (ACE, a type of limited activity protease or peptidase) inhibitors has made a significant impact on the treatment of hypertension. Lastly, the restitution of normal antiprotease levels by the infusion of the purified protein in patients with genetic alpha-1-antiprotease deficiency is regularly being used to reduce the rate of lung function 1055 caused by the unopposed activity of human neutrophil elastase in these individuals.

Overview.- Proteases — Structures, Mechanisms and Inhibitors.- Biochemical Mechanisms for Disrupting the Proteinase-Proteinase Inhibitor Balance in Tissues.- Oxidants, Metalloproteases and Serine Proteases in Inflammation.- Elastase and Oxygen Radicals: Synergistic Interactions.- Neutrophil Elastase Inhibitors: Clinical Potential.- Proteolysis-Induced Pathomechanisms in Acute Inflammation and Related Therapeutic Approaches.- Synthesis and Characterization of Human Neutrophil Elastase Inhibitors Derived from Aromatic Esters of Phenylalkanoic Acids.- In Vivo Evaluation of MDL 201,404YA, A Novel Inhibitor of Human Neutrophil Elastase.- Alpha1-Antitrypsin Augmentation Therapy.- Secretory Leukocyte Protease Inhibitor in Cystic Fibrosis.- Oxidation Resistant Muteins of Antileukoproteinase as Potential Therapeutic Agents.- Proteases and Protease-Derived Peptides in Inflammation.- Factor XII Activation and Inhibition in Inflammation.- The Kinin System in Inflammation.- Role of Bradykinin in Microbial Infection: Enhancement of Septicemia by Microbial Proteases and Kinin.- Kinin Antagonists as Human Therapeutics.- Proteases in Immunoregulation and Cellular Differentiation.- Cytokine Regulation of Endothelial Cell Extracellular Proteolysis.- Different Functional Share of Individual Lysosomal Cathepsins in Normal and Pathological Conditions.- Neuropeptide Processing in Pathophysiology.- Resolution of limp-Free and Timp-Complexed 70kDa Progelatinase from Culture Medium of Rous Sarcoma Virus-Transformed Chicken.- Endotoxin and Eicosanoids.